相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Early Impact of Human Papillomavirus Vaccination on Cervical NeoplasiauNationwide Follow-up of Young Danish Women
Birgitte Baldur-Felskov et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys
Emily A. Burger et al.
PLOS ONE (2014)
Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010
Lauri E. Markowitz et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
Amy Leval et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine
Hugo C. Turner et al.
PLOS ONE (2013)
Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data
Hammad Ali et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
E. A. Burger et al.
BRITISH JOURNAL OF CANCER (2012)
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
Talia Malagon et al.
LANCET INFECTIOUS DISEASES (2012)
Epidemiological aspects of recurrent respiratory papillomatosis: A population-based study
Turid Omland et al.
LARYNGOSCOPE (2012)
Quality of life valuations of HPV-associated cancer health states by the general population
E. Lynne Conway et al.
SEXUALLY TRANSMITTED INFECTIONS (2012)
Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries
Karen Canfell et al.
VACCINE (2012)
A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
John T. Schiller et al.
VACCINE (2012)
Human Papillomavirus Vaccine Introduction - The First Five Years
Lauri E. Markowitz et al.
VACCINE (2012)
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age
X. Castellsague et al.
BRITISH JOURNAL OF CANCER (2011)
The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK
S. C. Woodhall et al.
SEXUALLY TRANSMITTED INFECTIONS (2011)
Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark
Jens Olsen et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2010)
Age-Based Programs for Vaccination against HPV
Elamin H. Elbasha et al.
VALUE IN HEALTH (2009)
Papillomaviruses in the causation of human cancers - a brief historical account
Harald zur Hausen
VIROLOGY (2009)
Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
Jane J. Kim et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK
E. J. Dasbach et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2008)
Health and economic implications of HPV vaccination in the United States
Jane J. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model
Cara Usher et al.
VACCINE (2008)
Economic evaluation of human papillomavirus vaccination in the United Kingdom
Mark Jit et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection
Luisa L. Villa et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Multiparameter calibration of a natural history model of cervical cancer
Jane J. Kim et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease
Charles J. N. Lacey et al.
VACCINE (2006)